APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chloroquine Phosphate Tablets (COVID-19)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chloroquine Phosphate Tablets (COVID-19) Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchChloroquine Phosphate Tablets (COVID-19) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Chloroquine Phosphate Tablets (COVID-19) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Chloroquine Phosphate Tablets (COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chloroquine Phosphate Tablets (COVID-19) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Chloroquine Phosphate Tablets (COVID-19) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Chloroquine Phosphate Tablets (COVID-19) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chloroquine Phosphate Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chloroquine Phosphate Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chloroquine Phosphate Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chloroquine Phosphate Tablets (COVID-19) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chloroquine Phosphate Tablets (COVID-19) market include Zhongsheng Pharma, Sichuan Sunny Hope, CSPC Group, Shanghai Pharma, KPC Group, Jinghua Pharmaceutical Group, North China Pharmaceutical Group, Guangzhou Baiyunshan Guanghua Pharmaceutical and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chloroquine Phosphate Tablets (COVID-19) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chloroquine Phosphate Tablets (COVID-19) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chloroquine Phosphate Tablets (COVID-19) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chloroquine Phosphate Tablets (COVID-19) market size, projected growth trends, production technologies, key applications, and end-use industries.

Chloroquine Phosphate Tablets (COVID-19) Segment by Company

Zhongsheng Pharma

Sichuan Sunny Hope

CSPC Group

Shanghai Pharma

KPC Group

Jinghua Pharmaceutical Group

North China Pharmaceutical Group

Guangzhou Baiyunshan Guanghua Pharmaceutical

Bayer

Sun Pharma

Rising Pharmaceutical

Chloroquine Phosphate Tablets (COVID-19) Segment by Type

250mg

500mg

Chloroquine Phosphate Tablets (COVID-19) Segment by Application

Arthritis

Malaria

COVID-19

Others

Chloroquine Phosphate Tablets (COVID-19) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Chloroquine Phosphate Tablets (COVID-19) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chloroquine Phosphate Tablets (COVID-19) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chloroquine Phosphate Tablets (COVID-19) significant trends, drivers, influence factors in global and regions.

6. To analyze Chloroquine Phosphate Tablets (COVID-19) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Phosphate Tablets (COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Phosphate Tablets (COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Phosphate Tablets (COVID-19).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chloroquine Phosphate Tablets (COVID-19) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chloroquine Phosphate Tablets (COVID-19) industry.

Chapter 3: Detailed analysis of Chloroquine Phosphate Tablets (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chloroquine Phosphate Tablets (COVID-19) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chloroquine Phosphate Tablets (COVID-19) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chloroquine Phosphate Tablets (COVID-19) Industry Trends Table 2. Chloroquine Phosphate Tablets (COVID-19) Industry Drivers Table 3. Chloroquine Phosphate Tablets (COVID-19) Industry Opportunities and Challenges Table 4. Chloroquine Phosphate Tablets (COVID-19) Industry Restraints Table 5. Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chloroquine Phosphate Tablets (COVID-19) Revenue Share by Company (2021-2026) Table 7. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Company (2021-2026) Table 9. Global Chloroquine Phosphate Tablets (COVID-19) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Chloroquine Phosphate Tablets (COVID-19) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chloroquine Phosphate Tablets (COVID-19) Key Company Manufacturing Base & Headquarters Table 12. Global Chloroquine Phosphate Tablets (COVID-19) Company, Product Type & Application Table 13. Global Chloroquine Phosphate Tablets (COVID-19) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chloroquine Phosphate Tablets (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 250mg Table 18. Significant Companies of 500mg Table 19. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Type (2021-2026) Table 23. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Type (2027-2032) Table 24. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type (2021-2026) Table 28. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Arthritis Table 30. Significant Companies of Malaria Table 31. Significant Companies of COVID-19 Table 32. Significant Companies of Others Table 33. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Application (2021-2026) Table 37. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Application (2027-2032) Table 38. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application (2021-2026) Table 42. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application (2027-2032) Table 43. Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region (2021-2026) & (K Units) Table 45. Global Chloroquine Phosphate Tablets (COVID-19) Sales Market Share by Region (2021-2026) Table 46. Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region (2027-2032) & (K Units) Table 47. Global Chloroquine Phosphate Tablets (COVID-19) Sales Market Share by Region (2027-2032) Table 48. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Region (2021-2026) Table 51. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Region (2027-2032) Table 53. Global Chloroquine Phosphate Tablets (COVID-19) Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Chloroquine Phosphate Tablets (COVID-19) Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Chloroquine Phosphate Tablets (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2021-2026) & (K Units) Table 58. Global Chloroquine Phosphate Tablets (COVID-19) Sales Market Share by Country (2021-2026) Table 59. Global Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2027-2032) & (K Units) Table 60. Global Chloroquine Phosphate Tablets (COVID-19) Sales Market Share by Country (2027-2032) Table 61. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Market Share by Country (2021-2026) Table 63. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Market Share by Country (2027-2032) Table 65. Zhongsheng Pharma Company Information Table 66. Zhongsheng Pharma Business Overview Table 67. Zhongsheng Pharma Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhongsheng Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 69. Zhongsheng Pharma Recent Development Table 70. Sichuan Sunny Hope Company Information Table 71. Sichuan Sunny Hope Business Overview Table 72. Sichuan Sunny Hope Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Sichuan Sunny Hope Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 74. Sichuan Sunny Hope Recent Development Table 75. CSPC Group Company Information Table 76. CSPC Group Business Overview Table 77. CSPC Group Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. CSPC Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 79. CSPC Group Recent Development Table 80. Shanghai Pharma Company Information Table 81. Shanghai Pharma Business Overview Table 82. Shanghai Pharma Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Shanghai Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 84. Shanghai Pharma Recent Development Table 85. KPC Group Company Information Table 86. KPC Group Business Overview Table 87. KPC Group Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. KPC Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 89. KPC Group Recent Development Table 90. Jinghua Pharmaceutical Group Company Information Table 91. Jinghua Pharmaceutical Group Business Overview Table 92. Jinghua Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Jinghua Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 94. Jinghua Pharmaceutical Group Recent Development Table 95. North China Pharmaceutical Group Company Information Table 96. North China Pharmaceutical Group Business Overview Table 97. North China Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. North China Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 99. North China Pharmaceutical Group Recent Development Table 100. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information Table 101. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 102. Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 104. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 105. Bayer Company Information Table 106. Bayer Business Overview Table 107. Bayer Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bayer Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 109. Bayer Recent Development Table 110. Sun Pharma Company Information Table 111. Sun Pharma Business Overview Table 112. Sun Pharma Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sun Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 114. Sun Pharma Recent Development Table 115. Rising Pharmaceutical Company Information Table 116. Rising Pharmaceutical Business Overview Table 117. Rising Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Rising Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Product Portfolio Table 119. Rising Pharmaceutical Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Chloroquine Phosphate Tablets (COVID-19) Distributors List Table 123. Chloroquine Phosphate Tablets (COVID-19) Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Chloroquine Phosphate Tablets (COVID-19) Product Image Figure 2. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chloroquine Phosphate Tablets (COVID-19) Sales (2021-2032) & (K Units) Figure 5. Global Chloroquine Phosphate Tablets (COVID-19) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Chloroquine Phosphate Tablets (COVID-19) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 250mg Image Figure 10. 500mg Image Figure 11. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Type (2021-2032) Figure 14. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type (2021-2032) Figure 17. Arthritis Image Figure 18. Malaria Image Figure 19. COVID-19 Image Figure 20. Others Image Figure 21. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Application (2021-2032) Figure 24. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application (2021-2032) Figure 27. Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Chloroquine Phosphate Tablets (COVID-19) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Chloroquine Phosphate Tablets (COVID-19) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Chloroquine Phosphate Tablets (COVID-19) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 250mg
  • 500mg
Applications
  • Arthritis
  • Malaria
  • COVID-19
  • Others
Companies covered
  • Zhongsheng Pharma
  • Sichuan Sunny Hope
  • CSPC Group
  • Shanghai Pharma
  • KPC Group
  • Jinghua Pharmaceutical Group
  • North China Pharmaceutical Group
  • Guangzhou Baiyunshan Guanghua Pharmaceutical
  • Bayer
  • Sun Pharma
  • Rising Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032)
  4. 1.2.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume (2021-2032)
  5. 1.2.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chloroquine Phosphate Tablets (COVID-19) Market Dynamics
  1. 2.1 Chloroquine Phosphate Tablets (COVID-19) Industry Trends
  2. 2.2 Chloroquine Phosphate Tablets (COVID-19) Industry Drivers
  3. 2.3 Chloroquine Phosphate Tablets (COVID-19) Industry Opportunities and Challenges
  4. 2.4 Chloroquine Phosphate Tablets (COVID-19) Industry Restraints
3 Chloroquine Phosphate Tablets (COVID-19) Market by Company
  1. 3.1 Global Chloroquine Phosphate Tablets (COVID-19) Company Revenue Ranking in 2025
  2. 3.2 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Company (2021-2026)
  3. 3.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Company (2021-2026)
  4. 3.4 Global Chloroquine Phosphate Tablets (COVID-19) Average Price by Company (2021-2026)
  5. 3.5 Global Chloroquine Phosphate Tablets (COVID-19) Company Ranking (2024-2026)
  6. 3.6 Global Chloroquine Phosphate Tablets (COVID-19) Company Manufacturing Base and Headquarters
  7. 3.7 Global Chloroquine Phosphate Tablets (COVID-19) Company Product Type and Application
  8. 3.8 Global Chloroquine Phosphate Tablets (COVID-19) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chloroquine Phosphate Tablets (COVID-19) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chloroquine Phosphate Tablets (COVID-19) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chloroquine Phosphate Tablets (COVID-19) Market by Type
  1. 4.1 Chloroquine Phosphate Tablets (COVID-19) Type Introduction
  2. 4.1.1 250mg
  3. 4.1.2 500mg
  4. 4.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Type
  5. 4.2.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Type
  9. 4.3.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type (2021-2032)
5 Chloroquine Phosphate Tablets (COVID-19) Market by Application
  1. 5.1 Chloroquine Phosphate Tablets (COVID-19) Application Introduction
  2. 5.1.1 Arthritis
  3. 5.1.2 Malaria
  4. 5.1.3 COVID-19
  5. 5.1.4 Others
  6. 5.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Application
  7. 5.2.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Application
  11. 5.3.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application (2021-2032)
6 Chloroquine Phosphate Tablets (COVID-19) Regional Sales and Value Analysis
  1. 6.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region (2021-2032)
  3. 6.2.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region: 2021-2026
  4. 6.2.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region (2027-2032)
  5. 6.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Region (2027-2032)
  9. 6.5 Global Chloroquine Phosphate Tablets (COVID-19) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032)
  12. 6.6.2 North America Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032)
  15. 6.7.2 Europe Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032)
  21. 6.9.2 South America Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chloroquine Phosphate Tablets (COVID-19) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Country, 2025 VS 2032
7 Chloroquine Phosphate Tablets (COVID-19) Country-level Sales and Value Analysis
  1. 7.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2021-2032)
  4. 7.3.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2021-2026)
  5. 7.3.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2027-2032)
  6. 7.4 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chloroquine Phosphate Tablets (COVID-19) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chloroquine Phosphate Tablets (COVID-19) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongsheng Pharma
  2. 8.1.1 Zhongsheng Pharma Company Information
  3. 8.1.2 Zhongsheng Pharma Business Overview
  4. 8.1.3 Zhongsheng Pharma Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhongsheng Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  6. 8.1.5 Zhongsheng Pharma Recent Developments
  7. 8.2 Sichuan Sunny Hope
  8. 8.2.1 Sichuan Sunny Hope Company Information
  9. 8.2.2 Sichuan Sunny Hope Business Overview
  10. 8.2.3 Sichuan Sunny Hope Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Sunny Hope Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  12. 8.2.5 Sichuan Sunny Hope Recent Developments
  13. 8.3 CSPC Group
  14. 8.3.1 CSPC Group Company Information
  15. 8.3.2 CSPC Group Business Overview
  16. 8.3.3 CSPC Group Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CSPC Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  18. 8.3.5 CSPC Group Recent Developments
  19. 8.4 Shanghai Pharma
  20. 8.4.1 Shanghai Pharma Company Information
  21. 8.4.2 Shanghai Pharma Business Overview
  22. 8.4.3 Shanghai Pharma Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  24. 8.4.5 Shanghai Pharma Recent Developments
  25. 8.5 KPC Group
  26. 8.5.1 KPC Group Company Information
  27. 8.5.2 KPC Group Business Overview
  28. 8.5.3 KPC Group Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 KPC Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  30. 8.5.5 KPC Group Recent Developments
  31. 8.6 Jinghua Pharmaceutical Group
  32. 8.6.1 Jinghua Pharmaceutical Group Company Information
  33. 8.6.2 Jinghua Pharmaceutical Group Business Overview
  34. 8.6.3 Jinghua Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinghua Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  36. 8.6.5 Jinghua Pharmaceutical Group Recent Developments
  37. 8.7 North China Pharmaceutical Group
  38. 8.7.1 North China Pharmaceutical Group Company Information
  39. 8.7.2 North China Pharmaceutical Group Business Overview
  40. 8.7.3 North China Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 North China Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  42. 8.7.5 North China Pharmaceutical Group Recent Developments
  43. 8.8 Guangzhou Baiyunshan Guanghua Pharmaceutical
  44. 8.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  45. 8.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  46. 8.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  48. 8.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 Sun Pharma
  56. 8.10.1 Sun Pharma Company Information
  57. 8.10.2 Sun Pharma Business Overview
  58. 8.10.3 Sun Pharma Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  60. 8.10.5 Sun Pharma Recent Developments
  61. 8.11 Rising Pharmaceutical
  62. 8.11.1 Rising Pharmaceutical Company Information
  63. 8.11.2 Rising Pharmaceutical Business Overview
  64. 8.11.3 Rising Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Rising Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
  66. 8.11.5 Rising Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chloroquine Phosphate Tablets (COVID-19) Value Chain Analysis
  2. 9.1.1 Chloroquine Phosphate Tablets (COVID-19) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chloroquine Phosphate Tablets (COVID-19) Sales Mode & Process
  6. 9.2 Chloroquine Phosphate Tablets (COVID-19) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chloroquine Phosphate Tablets (COVID-19) Distributors
  9. 9.2.3 Chloroquine Phosphate Tablets (COVID-19) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst